Achieve the Holy Grail of Nutritional, Health, & Immunological Human Breast Milk Benefits by Advancing the Development of Bioactive Ingredients with Regulatory Compliance
The Infant Formula Industry Is Under Pressure.
Rising scrutiny of ingredient safety, alongside growing uncertainty amidst government initiatives have pushed the infant formula sector into the spotlight.
Regulators want tighter compliance. Consumers want total transparency. And the industry must deliver ingredients that are validated, scalable, and unquestionably safe. That’s where the 3rd Novel Ingredients for Infant Formula Summit comes in.
Across the industry, innovators are racing to close the nutritional and functional gap between formula and human breast milk, advancing HMOs, lactoferrin, osteopontin, lysozyme, and next‑generation lipids from discovery to real‑world application.
But getting there requires more than great science: it demands regulatory clarity, market readiness, and the ability to scale without compromising trust.
This summit brought together R&D leaders, ingredient innovators, infant formula manufacturers, food-tech pioneers, academic specialists, regulatory officials, and commercial strategists to accelerate the advancement of novel ingredients from early concept through approval and market launch.
With 70+ experts from companies including Bobbie Baby, Kendal Nutricare, Ausnutria, Mead Johnson Nutrition, Arla Food Ingredients, and Novonesis, the community unpacked global submission pathways, explored the impact of regulatory initiatives, and addressed formulation, stability, and clinical validation challenges.
Building on its success, the summit will return in 2027 to continue driving innovation and collaboration across the industry.
It was a wonderful event. Main positives in my opinion would be the small size of the conference and the concentrated focus of attendees, facilitating collaboration and networking.
Nicole Kaplan, Senior Lead, Helaina
The event was very well organized and was a wonderful opportunity to network with so many key people. The relevance of each of the speaker's talks were great and provided a wonderful update to important issues in our industry.
Joyce Stefan, Regional Sales & Account Manager, Arla Foods Ingredients
Good selection of industry and academic representatives. Good selection of topics. Good format that opened the opportunity for dialogue.
Vanessa Feher Castagna, Vice President - Research & Development, TurtleTree
Explore the 2026 Full Event Guide
- Discover 70+ R&D, regulatory, and commercial leaders from ingredient providers, infant formula manufacturers, foodtech innovators, academia, and government
- Preview 2 days of exclusive insights across novel bioactive discovery, clinical validation, regulatory approval pathways, and formulation challenges
- Discover the 16+ industry-leading voices from Bobbie, Arla, Kendal Nutricare, Novonesis, FrieslandCampina, and more
- Explore dedicated deep-dive sessions navigating evidence expectations in infant formulation, approval pathways & more
- Share easily with your team to assess and mobilize interest
Official 2026 Partners
Attending Companies Included
Explore the 2026 Agenda
The summit featured forward-looking sessions on novel bioactives, clinical validation strategies, global regulatory pathways, formulation challenges, and commercial scale-up shaping the future of infant nutrition.
Partner With Us
Connect with senior R&D, regulatory, and commercial leaders across ingredient providers, formula manufacturers, and foodtech companies seeking innovative, evidence-backed solutions to accelerate safe market entry
Join Industry Leaders
Network with decision-makers and innovators defining the next generation of clinically validated regulatory-ready ingredients designed to narrow the gap between formula and human breast milk